Pfizer plans to exit GSK consumer health unit Haleon after spinoff

Jun. 01, 2022 4:53 AM ETGSK plc (GSK), PFEBy: Ravikash, SA News Editor15 Comments

GlaxoSmithKline Headquarters In Brentford, London

Leon Neal/Getty Images News

Pfizer (NYSE:PFE) intends to exit its 32% stake in Haleon, GSK's (NYSE:GSK) consumer healthcare business which is headed for a spinoff in July.

GSK said that following the demerger, Pfizer intends to exit its 32% ownership interest in

Recommended For You

Comments (15)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.